Pocket Warming of Epidural Medication
1 other identifier
interventional
139
1 country
1
Brief Summary
This study will examine recent claims regarding the beneficial effect of warming epidural medications in order to hasten the onset of labor analgesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2016
CompletedFirst Posted
Study publicly available on registry
September 23, 2016
CompletedStudy Start
First participant enrolled
September 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedFebruary 25, 2026
February 1, 2026
1.3 years
May 2, 2016
February 23, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Time until pain score less than or equal to 3
Assess pain level regularly during labor
duration of labor and delivery
Secondary Outcomes (4)
Labor analgesia satisfaction
first hour of epidural administration
Vital Signs
during labor and delivery
Breakthrough pain
during labor
Mode of delivery
Delivery
Study Arms (2)
Pocket-warmed epidural medication
EXPERIMENTALThis arm will consist of pocket-warmed epidural medications to be administered per standard protocol to patients randomized to this group; this group is the pocket-warming group.
Room-temperature epidural medication
ACTIVE COMPARATORThis arm will consist of room-temperature epidural medications to be administered per standard protocol to patients randomized to this group. This group has no experimental intervention; standard of care labor epidural.
Interventions
Labor epidural medication administered per standard of care; no pocket warming.
Eligibility Criteria
You may qualify if:
- Women with a single vertex presentation fetus at term (38-42 weeks)
- Intact fetal membranes or membrane rupture \<6 hours previously
- Request to have an epidural for labor analgesia
- Provide written consent for the study.
You may not qualify if:
- Patients being treated/managed for chronic pain
- Allergies or significant adverse reactions to local anesthetic or opioid medications
- Contraindication to labor epidural placement
- Patients with history of spine abnormalities or spine surgery
- Clinical signs or symptoms of infection
- Baseline temperature \> 37.6 °C
- Non-English speaking
- Prisoners
- Age less than 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ohio State University Wexner Medical Center
Columbus, Ohio, 43210, United States
Study Officials
- PRINCIPAL INVESTIGATOR
John Coffman, MD
Ohio State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor-Clinical, Anesthesiology
Study Record Dates
First Submitted
May 2, 2016
First Posted
September 23, 2016
Study Start
September 30, 2024
Primary Completion
December 31, 2025
Study Completion
January 31, 2026
Last Updated
February 25, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share